Abstract
Asthma is a heterogeneous disease of the airways with a high prevalence worldwide characterized by chronic inflammation [...]
Reference17 articles.
1. 2021 GINA Report, Global Management for Asthma Management and Prevention (2021 Update). 2022.
2. Bakakos, P., Kostikas, K., Loukides, S., Makris, M., Papadopoulos, N.G., Steiropoulos, P., Tryfon, S., and Zervas, E. Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity. J. Pers. Med., 2022. 12.
3. Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma;O’Byrne;N. Engl. J. Med.,2018
4. As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma;Bateman;N. Engl. J. Med.,2018
5. Severe Adult Asthmas, Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes;Wenzel;Am. J. Respir. Crit. Care Med.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献